Hi Jan - happy to see you here! :)
To add to this discussion, our experience was that even pre-MDR, some competent authorities were requiring implant cards for implantable devices in clinical studies. It was years ago, but I want to say this included Germany and Italy, maybe others. It would be worth looking into whether there are still any local requirements in your countries of interest above those in MDR.
As others have said, the device will be in patients' bodies permanently, so whether or not it's in a study and regardless of the requirements it's good practice to have something for your patients to keep to inform their providers about the implant, particularly if there's any chance of interference (e.g., MRI). The MDCG 2019-8 guidance is very helpful in laying out the format and content of the implant card, so it's not hard to develop one; the hardest part is the logistics of printing and inserting into the package (and of course, ensuring your packaging testing supports the extra paper in the package).
Good luck!
Jennifer
------------------------------
Jennifer Cabralda RAC
Director, Regulatory Affairs
Coquitlam BC
Canada
------------------------------
Original Message:
Sent: 16-Jun-2023 08:05
From: Jan Flegeau
Subject: Article 18- First in Man-- Implant card and Patient Information Guide/Leaflet
I am hoping someone could help me out here. <o:p></o:p>
<o:p> </o:p>
If we would like to conduct a First in Man study in the EU for an implantable device, after the procedure, do we need to provide the patient with a Implant Card AND a Patient Information Leaflet/Guide?<o:p></o:p>
<o:p> </o:p>
Or is this only required once the device is MDR / CE approved and on the market?<o:p></o:p>
<o:p> </o:p>
Please advise.<o:p></o:p>
------------------------------
Jan Flegeau
------------------------------